X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1410) 1410
Publication (100) 100
Book Review (8) 8
Magazine Article (4) 4
Data Set (2) 2
Book Chapter (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1315) 1315
male (817) 817
female (813) 813
antineoplastic combined chemotherapy protocols - therapeutic use (805) 805
middle aged (743) 743
idarubicin - administration & dosage (724) 724
adult (688) 688
hematology (610) 610
cytarabine - administration & dosage (552) 552
aged (523) 523
oncology (523) 523
idarubicin (514) 514
leukemia, myeloid, acute - drug therapy (406) 406
remission induction (391) 391
idarubicin - therapeutic use (361) 361
index medicus (345) 345
adolescent (338) 338
treatment outcome (333) 333
chemotherapy (330) 330
acute myelogenous leukemia (241) 241
antineoplastic combined chemotherapy protocols - adverse effects (230) 230
idarubicin - adverse effects (210) 210
cancer (200) 200
etoposide - administration & dosage (199) 199
acute myeloid-leukemia (194) 194
acute disease (190) 190
therapy (182) 182
disease-free survival (180) 180
acute myeloid leukemia (175) 175
daunorubicin - administration & dosage (175) 175
prognosis (164) 164
antineoplastic agents - therapeutic use (157) 157
antibiotics, antineoplastic - therapeutic use (155) 155
leukemia, myeloid - drug therapy (152) 152
cytarabine (151) 151
recurrence (150) 150
anthracyclines (147) 147
child (147) 147
leukemia, promyelocytic, acute - drug therapy (147) 147
cytarabine - therapeutic use (146) 146
daunorubicin (145) 145
daunorubicin - therapeutic use (142) 142
survival analysis (142) 142
antineoplastic combined chemotherapy protocols - administration & dosage (139) 139
leukemia (139) 139
aged, 80 and over (128) 128
survival rate (127) 127
leukemia, myeloid, acute - mortality (125) 125
cytosine-arabinoside (122) 122
combined modality therapy (121) 121
cytarabine - adverse effects (114) 114
daunorubicin - analogs & derivatives (114) 114
young adult (113) 113
pharmacology & pharmacy (112) 112
vidarabine - analogs & derivatives (110) 110
child, preschool (109) 109
tretinoin - administration & dosage (104) 104
animals (101) 101
aml (98) 98
dose-response relationship, drug (98) 98
drug administration schedule (98) 98
mitoxantrone - administration & dosage (98) 98
administration, oral (93) 93
acute promyelocytic leukemia (92) 92
drug evaluation (91) 91
retrospective studies (91) 91
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (87) 87
doxorubicin (86) 86
transplantation (85) 85
trial comparing idarubicin (84) 84
vidarabine - administration & dosage (84) 84
idarubicin - pharmacology (83) 83
follow-up studies (81) 81
infant (81) 81
survival (81) 81
leukemia, myeloid, acute - pathology (80) 80
hematopoietic stem cell transplantation (79) 79
leukemia, myeloid, acute - genetics (79) 79
acute nonlymphocytic leukemia (76) 76
antibiotics, antineoplastic - administration & dosage (76) 76
cyclophosphamide - administration & dosage (76) 76
time factors (75) 75
medicine & public health (74) 74
adult patients (73) 73
daunorubicin - adverse effects (73) 73
leukemia, myeloid, acute - therapy (73) 73
prospective studies (72) 72
remission (71) 71
colony-stimulating factor (70) 70
bone-marrow transplantation (69) 69
bone marrow transplantation (67) 67
tretinoin - therapeutic use (67) 67
antibiotics, antineoplastic - adverse effects (66) 66
trial (65) 65
trans-retinoic acid (63) 63
leukemia - drug therapy (62) 62
relapse (62) 62
risk factors (62) 62
fludarabine (60) 60
vincristine - administration & dosage (60) 60
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1335) 1335
Japanese (27) 27
Chinese (17) 17
German (7) 7
Spanish (7) 7
French (5) 5
Italian (5) 5
Hungarian (4) 4
Polish (4) 4
Russian (4) 4
Czech (1) 1
Dutch (1) 1
Portuguese (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 08/2012, Volume 120, Issue 8, pp. 1570 - 1580
Journal Article
Blood, ISSN 0006-4971, 10/2010, Volume 116, Issue 17, pp. 3171 - 3179
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 13, pp. 1295 - 1305
Journal Article
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9757, pp. 2009 - 2017
Summary Background Although survival of children with acute lymphoblastic leukaemia has improved greatly in the past two decades, the outcome of those who... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | IDARUBICIN | THERAPY | DOSE ARA-C | PEDIATRIC-PATIENTS | SENSITIVITY | RISK | CHILDHOOD LEUKEMIA | EXPERIENCE | ACCELERATED APPROVAL | ONCOLOGY GROUP | Recurrence | Cyclophosphamide - administration & dosage | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Infant | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Vincristine - administration & dosage | Female | Leukocyte Count | Child | Idarubicin - therapeutic use | Mitoxantrone - therapeutic use | Dexamethasone - administration & dosage | Risk Assessment | Kaplan-Meier Estimate | Mercaptopurine - administration & dosage | Etoposide - administration & dosage | Treatment Outcome | United Kingdom | Vidarabine - analogs & derivatives | Cytarabine - administration & dosage | Polyethylene Glycols - administration & dosage | Asparaginase - administration & dosage | Disease-Free Survival | Antibiotics, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Methotrexate - administration & dosage | Vidarabine - administration & dosage | Complications and side effects | Dosage and administration | Acute lymphocytic leukemia | Drug therapy | Patient outcomes | Mitoxantrone hydrochloride | Studies | Design | Medical research | Chemotherapy | Cytogenetics | Cancer therapies | Data bases | Cancer | Ovarian cancer
Journal Article
Journal Article
Journal Article
Blood, ISSN 0006-4971, 2013, Volume 121, Issue 14, pp. 2618 - 2626
Journal Article